Importantly, this slowing of EEG correlates with gold standard biomarkers of AD, such as Fluorodeoxyglucose-PET images [76] and phosphorylated tau and/or Aβ42 measured in CSF [77,78,79,80]. This evidence concerns the gene MAPT and Alzheimer disease.